Wealthsource Partners LLC acquired a new position in Express Scripts Holding Co (NASDAQ:ESRX) in the 3rd quarter, HoldingsChannel reports. The firm acquired 2,276 shares of the company’s stock, valued at approximately $216,000.

Other institutional investors have also added to or reduced their stakes in the company. TRUE Private Wealth Advisors acquired a new stake in shares of Express Scripts in the third quarter worth $115,000. Palo Capital Inc. acquired a new stake in shares of Express Scripts in the third quarter worth $124,000. Landaas & Co. WI ADV acquired a new stake in shares of Express Scripts in the second quarter worth $102,000. Sun Life Financial INC increased its position in shares of Express Scripts by 758.8% in the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after acquiring an additional 1,343 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. increased its position in shares of Express Scripts by 3,048.1% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock worth $126,000 after acquiring an additional 1,585 shares in the last quarter. 85.02% of the stock is owned by institutional investors.

In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total transaction of $520,783.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.79% of the company’s stock.

ESRX opened at $95.85 on Friday. The firm has a market cap of $55.25 billion, a P/E ratio of 13.50, a PEG ratio of 1.23 and a beta of 0.88. Express Scripts Holding Co has a twelve month low of $66.93 and a twelve month high of $101.73. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.42 by $0.01. The business had revenue of $25.56 billion during the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the business earned $2.51 EPS. Equities analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current year.

Several research firms have recently issued reports on ESRX. Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Wednesday. Mizuho set a $101.00 price objective on shares of Express Scripts and gave the stock a “hold” rating in a research report on Monday, November 5th. William Blair lowered shares of Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 31st. Cowen reissued a “buy” rating and issued a $88.00 price objective on shares of Express Scripts in a research report on Friday, November 2nd. Finally, Barclays increased their price objective on shares of Express Scripts from $83.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 1st. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Hold” and an average target price of $92.14.

TRADEMARK VIOLATION WARNING: This piece was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/wealthsource-partners-llc-acquires-new-stake-in-express-scripts-holding-co-esrx/2670662.html.

Express Scripts Company Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

See Also: Stop Order

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.